BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

AstraZeneca

AstraZeneca logo

Founded
1999
Patents
111
Clinical Trials
2823
Publications
133

Technologies

Antisense Oligonucleotides

AstraZeneca is global innovation-driven biopharmaceutical company specialising in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare.

AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. They also focus on getting the best from every medicine they make by exploring all the ways it can be used or improved.

Their business strategy sets out their path to success in delivering great medicines to patients through innovative science and global excellence in development and commercialisation.


Posts Mentioning This Company

Antisense Oligonucleotides Make Sense

  
Antisense oligonucleotides (ASOs) are short (about 12 to 25 nucleotides long), synthetic single strands of DNA or RNA that are complementary to a chosen sequence. They can alter RNA and reduce, restore, or modify protein expression. ASOs interact with proteins on the surface of cells and enter the cytoplasm. Then …